1. WISP3 mutation associated with pseudorheumatoid dysplasia
- Author
-
M. Reza Sailani, Safoura Mazrouei, Anil Narasimha, Jonathan A. Bernstein, Amin Zia, Janet Linnea Lynch, Omid Aryani, Michael Snyder, Inlora Jingga, and James Chappell
- Subjects
030203 arthritis & rheumatology ,0301 basic medicine ,Research Report ,Pathology ,medicine.medical_specialty ,Spondyloepimetaphyseal dysplasia ,Consanguineous family ,business.industry ,Articular cartilage ,General Medicine ,medicine.disease ,Progressive pseudorheumatoid dysplasia ,WISP3 Gene ,spondyloepimetaphyseal dysplasia ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Dysplasia ,Mutation (genetic algorithm) ,Medicine ,Multiple skeletal anomalies ,business ,multiple skeletal anomalies - Abstract
Progressive pseudorheumatoid dysplasia (PPD) is a skeletal dysplasia characterized by predominant involvement of articular cartilage with progressive joint stiffness. Here we report genetic characterization of a consanguineous family segregating an uncharacterized from of skeletal dysplasia. Whole-exome sequencing of four affected siblings and their parents identified a loss-of-function homozygous mutation in the WISP3 gene, leading to diagnosis of PPD in the affected individuals. The identified variant (Chr6: 112382301; WISP3:c.156C>A p.Cys52*) is rare and predicted to cause premature termination of the WISP3 protein.
- Published
- 2018